B G Leventhal

838 total citations
17 papers, 638 citations indexed

About

B G Leventhal is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Molecular Biology. According to data from OpenAlex, B G Leventhal has authored 17 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in B G Leventhal's work include Acute Lymphoblastic Leukemia research (7 papers), Neuroblastoma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). B G Leventhal is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Neuroblastoma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). B G Leventhal collaborates with scholars based in United States and Canada. B G Leventhal's co-authors include RF Ambinder, E. M. E. MacMahon, Victòria Cardona, Ivette Lorenzana, Humberto Cosenza, Seymour Grufferman, Shiao Y. Woo, David C. McCullough, Laurence Champion and L. F. Sinks and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Roentgenology.

In The Last Decade

B G Leventhal

16 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B G Leventhal United States 13 307 198 130 111 110 17 638
EP Smith United States 8 256 0.8× 171 0.9× 134 1.0× 108 1.0× 44 0.4× 11 697
J. C. O’Keane Ireland 15 248 0.8× 161 0.8× 157 1.2× 47 0.4× 79 0.7× 28 737
Rosanna Scimè Italy 18 403 1.3× 271 1.4× 117 0.9× 96 0.9× 123 1.1× 51 1.2k
Peter Schauer United States 11 218 0.7× 114 0.6× 67 0.5× 35 0.3× 82 0.7× 13 629
Anne Bukh Denmark 16 156 0.5× 362 1.8× 85 0.7× 40 0.4× 167 1.5× 35 789
Katharina Troppan Austria 16 222 0.7× 254 1.3× 112 0.9× 104 0.9× 139 1.3× 27 641
Daniele Mattei Italy 11 200 0.7× 157 0.8× 118 0.9× 128 1.2× 59 0.5× 24 665
M N Koss United States 17 275 0.9× 129 0.7× 323 2.5× 66 0.6× 217 2.0× 26 1.1k
D Valteau France 13 198 0.6× 67 0.3× 65 0.5× 48 0.4× 91 0.8× 20 497
H. Baurmann Germany 18 211 0.7× 86 0.4× 61 0.5× 109 1.0× 180 1.6× 61 1.2k

Countries citing papers authored by B G Leventhal

Since Specialization
Citations

This map shows the geographic impact of B G Leventhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B G Leventhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B G Leventhal more than expected).

Fields of papers citing papers by B G Leventhal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B G Leventhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B G Leventhal. The network helps show where B G Leventhal may publish in the future.

Co-authorship network of co-authors of B G Leventhal

This figure shows the co-authorship network connecting the top 25 collaborators of B G Leventhal. A scholar is included among the top collaborators of B G Leventhal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B G Leventhal. B G Leventhal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Graham, Michael L., Jonathan J. Shuster, B A Kamen, et al.. (1996). Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.. PubMed. 2(2). 331–7. 14 indexed citations
2.
Castleberry, R P, Alan Cantor, V. Joshi, et al.. (1994). Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 12(8). 1616–1620. 43 indexed citations
3.
Mendenhall, Nancy P., Alan Cantor, Jennifer L. Williams, et al.. (1993). With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group study.. Journal of Clinical Oncology. 11(11). 2218–2225. 21 indexed citations
4.
Furman, Wayne L., Douglas Strother, Kenneth L. McClain, et al.. (1993). Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 11(11). 2205–2210. 39 indexed citations
5.
Ambinder, RF, et al.. (1993). Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood. 81(2). 462–467. 13 indexed citations
6.
Kato, Gregory J., JJ Shuster, James M. Boyett, et al.. (1993). High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood. 82(8). 2304–2309. 30 indexed citations
7.
Ambinder, RF, Ivette Lorenzana, B G Leventhal, et al.. (1993). Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood. 81(2). 462–467. 173 indexed citations
8.
Kato, Gregory J., JJ Shuster, James M. Boyett, et al.. (1993). High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood. 82(8). 2304–2309. 36 indexed citations
9.
10.
Steuber, C. Philip, Curt I. Civin, J. Krischer, et al.. (1991). A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study.. Journal of Clinical Oncology. 9(2). 247–258. 30 indexed citations
11.
Taylor, George A., Elizabeth J. Perlman, L.R. Scherer, et al.. (1991). Vascularity of tumors in children: evaluation with color Doppler imaging.. American Journal of Roentgenology. 157(6). 1267–1271. 23 indexed citations
12.
Leventhal, B G & Gregory J. Kato. (1990). Childhood Hodgkin and Non-Hodgkin Lymphomas. Pediatrics in Review. 12(6). 171–179.
13.
Wiley, Joseph M., Nathan Smith, B G Leventhal, et al.. (1990). Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.. Journal of Clinical Oncology. 8(2). 280–286. 87 indexed citations
14.
Steuber, C. Philip, Steven J. Culbert, Yaddanapudi Ravindranath, et al.. (1990). Therapy of Childhood Acute Nonlymphocytic Leukemia: The Pediatric Oncology Group Experience (1977–1988). Hämatologie und Bluttransfusion. 33. 198–209. 5 indexed citations
15.
Leventhal, B G. (1989). RANDOMIZED SURGICAL ADJUVANT TRIAL OF INTERFERON ALPHA-n1 IN RECURRENT PAPILLOMATOSIS. The Pediatric Infectious Disease Journal. 8(8). 546–546. 5 indexed citations
16.
Kashima, Haskins K., B G Leventhal, Phoebe Mounts, et al.. (1988). Interferon alfa‐n1 (wellferon)® in juvenile onset recurrent respiratory papillomatosis: Results of a randomized study in twelve collaborative institutions. The Laryngoscope. 98(3). 334–340. 35 indexed citations
17.
Wharam, Moody D., Laurence Champion, L. F. Sinks, et al.. (1982). Cisplatin therapy in recurrent childhood brain tumors.. PubMed. 66(12). 2013–20. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by EP Smith Breakdown of academic impact, for papers by J. C. O’Keane Breakdown of academic impact, for papers by Rosanna Scimè Breakdown of academic impact, for papers by Peter Schauer Breakdown of academic impact, for papers by Anne Bukh Breakdown of academic impact, for papers by Katharina Troppan Breakdown of academic impact, for papers by Daniele Mattei Breakdown of academic impact, for papers by M N Koss Breakdown of academic impact, for papers by D Valteau Breakdown of academic impact, for papers by H. Baurmann
Rankless by CCL
2026